Social media efficacy in crisis management: effectiveness of non-pharmaceutical interventions to manage COVID-19 challenges
Y Zhou, A Draghici, J Abbas, R Mubeen… - Frontiers in …, 2022 - frontiersin.org
The new identified virus COVID-19 has become one of the most contagious diseases in
human history. The ongoing coronavirus has created severe threats to global mental health …
human history. The ongoing coronavirus has created severe threats to global mental health …
SARS-CoV-2 immunity in animal models
Z Chen, Y Yuan, Q Hu, A Zhu, F Chen, S Li… - Cellular & molecular …, 2024 - nature.com
The COVID-19 pandemic, which was caused by severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2), has become a worldwide health crisis due to its …
coronavirus 2 (SARS-CoV-2), has become a worldwide health crisis due to its …
Adverse effects following anti–COVID-19 vaccination with mRNA-based BNT162b2 are alleviated by altering the route of administration and correlate with baseline …
Ensuring high vaccination and even booster vaccination coverage is critical in preventing
severe Coronavirus Disease 2019 (COVID-19). Among the various COVID-19 vaccines …
severe Coronavirus Disease 2019 (COVID-19). Among the various COVID-19 vaccines …
[HTML][HTML] Impairing RAGE signaling promotes survival and limits disease pathogenesis following SARS-CoV-2 infection in mice
F Jessop, B Schwarz, D Scott, LM Roberts… - JCI insight, 2022 - ncbi.nlm.nih.gov
Cellular and molecular mechanisms driving morbidity following SARS-CoV-2 infection have
not been well defined. The receptor for advanced glycation end products (RAGE) is a central …
not been well defined. The receptor for advanced glycation end products (RAGE) is a central …
Animal models for SARS‐CoV‐2 infection and pathology
Z Bi, W Hong, J Yang, S Lu, X Peng - MedComm, 2021 - Wiley Online Library
Severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) is the etiology of
coronavirus disease 2019 (COVID‐19) pandemic. Current variants including Alpha, Beta …
coronavirus disease 2019 (COVID‐19) pandemic. Current variants including Alpha, Beta …
Role of spike in the pathogenic and antigenic behavior of SARS-CoV-2 BA. 1 Omicron
The recently identified, globally predominant SARS-CoV-2 Omicron variant (BA. 1) is highly
transmissible, even in fully vaccinated individuals, and causes attenuated disease …
transmissible, even in fully vaccinated individuals, and causes attenuated disease …
RBD-VLP vaccines adjuvanted with Alum or SWE protect K18-hACE2 mice against SARS-CoV-2 VOC challenge
The ongoing COVID-19 pandemic has contributed largely to the global vaccine disparity.
Development of protein subunit vaccines can help alleviate shortages of COVID-19 vaccines …
Development of protein subunit vaccines can help alleviate shortages of COVID-19 vaccines …
Mouse models of lung-specific SARS-CoV-2 infection with moderate pathological traits
SH Kim, J Kim, JY Jang, H Noh, J Park… - Frontiers in …, 2022 - frontiersin.org
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) causing coronavirus
disease 2019 (COVID-19) has been a global health concern since 2019. The viral spike …
disease 2019 (COVID-19) has been a global health concern since 2019. The viral spike …
A novel hACE2 knock-in mouse model recapitulates pulmonary and intestinal SARS-CoV-2 infection
X Zhou, W Sun, Y Zhang, H Gu, R Wang, P Xie… - Frontiers in …, 2023 - frontiersin.org
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) transmission is
responsible for the coronavirus disease 2019 (COVID-19) pandemic. SARS-CoV-2 uses the …
responsible for the coronavirus disease 2019 (COVID-19) pandemic. SARS-CoV-2 uses the …
The lethal K18-hACE2 knock-in mouse model mimicking the severe pneumonia of COVID-19 is practicable for antiviral development
Z Zhang, L Zhou, Q Liu, Y Zheng, X Tan… - Emerging Microbes & …, 2024 - Taylor & Francis
Animal models of COVID-19 facilitate the development of vaccines and antivirals against
SARS-CoV-2. The efficacy of antivirals or vaccines may differ in different animal models with …
SARS-CoV-2. The efficacy of antivirals or vaccines may differ in different animal models with …